New Jersey’s life sciences sector is poised for continued growth in 2024, following a year in which the industry was a key source of demand for commercial real estate owners.
Another life sciences company is headed to Jersey City from Brooklyn under a newly completed lease with Thor Equities Group, in a deal arranged by brokers with JLL.
